+

WO2003105751A3 - Novel curcumin derivatives - Google Patents

Novel curcumin derivatives Download PDF

Info

Publication number
WO2003105751A3
WO2003105751A3 PCT/KR2002/001134 KR0201134W WO03105751A3 WO 2003105751 A3 WO2003105751 A3 WO 2003105751A3 KR 0201134 W KR0201134 W KR 0201134W WO 03105751 A3 WO03105751 A3 WO 03105751A3
Authority
WO
WIPO (PCT)
Prior art keywords
novel curcumin
curcumin derivatives
novel
pharmaceutical composition
curcumin derivative
Prior art date
Application number
PCT/KR2002/001134
Other languages
French (fr)
Other versions
WO2003105751A2 (en
Inventor
Ho-Jeong Kwon
Joong-Sup Shim
Jin-Hee Kim
Seung-Hoon Choi
Jong-Heon Shin
Jung-Rae Rho
Original Assignee
Ho-Jeong Kwon
Joong-Sup Shim
Jin-Hee Kim
Seung-Hoon Choi
Jong-Heon Shin
Jung-Rae Rho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ho-Jeong Kwon, Joong-Sup Shim, Jin-Hee Kim, Seung-Hoon Choi, Jong-Heon Shin, Jung-Rae Rho filed Critical Ho-Jeong Kwon
Priority to PCT/KR2002/001134 priority Critical patent/WO2003105751A2/en
Priority to AU2002314566A priority patent/AU2002314566A1/en
Publication of WO2003105751A2 publication Critical patent/WO2003105751A2/en
Publication of WO2003105751A3 publication Critical patent/WO2003105751A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/40—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C49/245—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings
    • C07C49/248—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a novel curcumin derivative and a pharmaceutical composition, in particular to a novel curcumin derivative with anti-angiogenic activity and a pharmaceutical composition for treating or preventing a disease associated with unregulated angiogenesis.
PCT/KR2002/001134 2002-06-17 2002-06-17 Novel curcumin derivatives WO2003105751A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/KR2002/001134 WO2003105751A2 (en) 2002-06-17 2002-06-17 Novel curcumin derivatives
AU2002314566A AU2002314566A1 (en) 2002-06-17 2002-06-17 Novel curcumin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2002/001134 WO2003105751A2 (en) 2002-06-17 2002-06-17 Novel curcumin derivatives

Publications (2)

Publication Number Publication Date
WO2003105751A2 WO2003105751A2 (en) 2003-12-24
WO2003105751A3 true WO2003105751A3 (en) 2004-09-23

Family

ID=29728585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2002/001134 WO2003105751A2 (en) 2002-06-17 2002-06-17 Novel curcumin derivatives

Country Status (2)

Country Link
AU (1) AU2002314566A1 (en)
WO (1) WO2003105751A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7597492B2 (en) 2023-03-01 2024-12-10 良丹 孫 Compounds used to inhibit the activity of AIM2 protein

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070093457A1 (en) * 2004-02-11 2007-04-26 Nadir Arber Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
JP5063351B2 (en) * 2004-09-17 2012-10-31 エグゼリクシス， インコーポレイテッド Pyrazole kinase modulator and methods of use
WO2009073050A2 (en) * 2007-07-27 2009-06-11 Research Foundation Of City University Of New York Use of curcumin to block brain tumor formation in vivo
EP2475769B1 (en) * 2009-09-07 2016-11-09 Jawaharlal Nehru Centre for Advanced Scientific Research Inhibition of histone acetyltransferases by ctk7a and methods thereof
KR101952222B1 (en) * 2011-04-11 2019-02-26 그린 테크 가부시키가이샤 Novel pyrazole derivative
KR102212146B1 (en) 2012-10-10 2021-02-03 그린 테크 가부시키가이샤 Novel pyrazole derivative
CN103333140A (en) * 2013-06-27 2013-10-02 河南工业大学 Preparation method of curcumin derivatives, and antitumor drug
RU2695062C2 (en) * 2015-05-22 2019-07-19 Общество С Ограниченной Ответственностью "Отечественные Фармацевтические Технологии" Novel 3,5-divinyl-pyrazole derivatives for medical use
CN106800547B (en) * 2017-01-03 2019-07-23 中国人民解放军第二军医大学 A kind of disubstituted aryl class compound and its application
CN107519544A (en) * 2017-08-28 2017-12-29 武汉杨森生物技术有限公司 Compound anticoagulant heparin coating microballoon and preparation method and application
WO2021105137A1 (en) 2019-11-25 2021-06-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Trem-1 inhibitors for the treatment of vaso-occlusions and tissue injuries in patients suffering from sickle cell disease
WO2022186362A1 (en) * 2021-03-03 2022-09-09 白鳥製薬株式会社 Method for producing pyrazole compound
WO2022189659A1 (en) 2021-03-12 2022-09-15 INSERM (Institut National de la Santé et de la Recherche Médicale) Trem-1 inhibitors for the treatment of marfan syndrome
WO2023061946A1 (en) 2021-10-11 2023-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of trem-1 for predicting and preventing postoperative complications after cardiac surgery with cardiopulmonary by-pass

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2501220A1 (en) * 1975-01-14 1976-07-15 Heumann Ludwig & Co Gmbh 1,7-Diphenyl-5-hydroxy-1,4,6,-heptatriene-3-ones prepn. - in one step from beta-diketones and aromatic aldehydes
EP0245825A1 (en) * 1986-05-09 1987-11-19 Warner-Lambert Company Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
WO1997016403A1 (en) * 1995-11-03 1997-05-09 Geneprint, Inc. Process for the synthesis of curcumin-related compounds
WO2001000201A1 (en) * 1999-06-30 2001-01-04 Emory University Curcumin and curcuminoid inhibition of angiogenesis
US20030203933A1 (en) * 2002-04-17 2003-10-30 Kuo-Hsiung Lee Novel curcumin analogues and uses thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2501220A1 (en) * 1975-01-14 1976-07-15 Heumann Ludwig & Co Gmbh 1,7-Diphenyl-5-hydroxy-1,4,6,-heptatriene-3-ones prepn. - in one step from beta-diketones and aromatic aldehydes
EP0245825A1 (en) * 1986-05-09 1987-11-19 Warner-Lambert Company Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
WO1997016403A1 (en) * 1995-11-03 1997-05-09 Geneprint, Inc. Process for the synthesis of curcumin-related compounds
WO2001000201A1 (en) * 1999-06-30 2001-01-04 Emory University Curcumin and curcuminoid inhibition of angiogenesis
US20030203933A1 (en) * 2002-04-17 2003-10-30 Kuo-Hsiung Lee Novel curcumin analogues and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CD Rompp Chemie Lexikon-Version 1.0, Stuttgart/New York: Georg Thieme Verlag 1995 *
DATABASE CAPLUS [online] CHOWDHURY HEMANTA ET AL.: "Isolation, characterization and insect growth inhibitory activity of major turmeric constituents and their derivatives against Schistocerca gregaria (Forsk) and Dysdercus koenigii (Walk)", XP002903668, accession no. stn Database accession no. 2000:872086 *
PEST MANAGEMENT SCIENCE, vol. 56, no. 12, 2000, pages 1086 - 1092 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7597492B2 (en) 2023-03-01 2024-12-10 良丹 孫 Compounds used to inhibit the activity of AIM2 protein

Also Published As

Publication number Publication date
AU2002314566A8 (en) 2003-12-31
WO2003105751A2 (en) 2003-12-24
AU2002314566A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU9163701A (en) Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
WO2003105751A3 (en) Novel curcumin derivatives
HK1077515A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
IL165696A0 (en) Substituted 1,3-diphenykprop-2-en-1-one derivatives and preparation and uses thereof
ZA200502247B (en) Selected CGRP antagonists, method for production and use thereof as medicament.
HK1084124A1 (en) Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
MXPA03007349A (en) Xanthine derivative, production and use thereof as a medicament.
ZA200305498B (en) Xanthine derivative, production and use thereof as a medicament.
WO2006125539A3 (en) Combination therapy comprising diaryl ureas for treating diseases
WO2009071690A3 (en) 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
DE60336336D1 (en) T THE BODY
PL394604A1 (en) Vinylazocycloalkanyl derivative, the use thereof and pharmaceutical composition
IT1306133B1 (en) COMPOSITION INCLUDING A CARNITINE AND A INOXITOLPHOSPHATE, USEFUL AS A DIETARY SUPPLEMENT OR MEDICATION.
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
SG148120A1 (en) An oral pharmaceutical and an oral care product
ATE465741T1 (en) 9A-CARBAMOYL-Y-AMINOPROPYL AND 9A-THIOCARBAMOYL-Y-AMINOPROPYL AZALIDES WITH ANTIMALARIA ACTIVITY
PL1838716T3 (en) Olanzapine pamoate dihydrate
IT1317841B1 (en) 3,9-DIAZABICYCLE DERIVATIVES (3.3.1) NONANAL ANALGESIC ACTIVITY.
MX2008006476A (en) Lipopeptide compositions.
TWI349545B (en) Pharmaceutical composition
NL1023797A1 (en) Pharmaceutical dosage form that bears pregnancy-friendly decorations.
IL191560A0 (en) 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
AU2003275360A8 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
SG148118A1 (en) An oral product, the preparing method and the use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1020047020459

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020047020459

Country of ref document: KR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载